- Home
- NTRB
NTRB
Nutriband Inc.
as 04-25-2025 4:00pm EST
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | ORLANDO |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $13.00 | AVG Volume (30 days): | 13.0K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.30 - $11.78 | Next Earning Date: | 05-30-2025 |
| Revenue: | $2,021,771 | Revenue Growth: | -3.18% |
| Revenue Growth (this year): | 7.95% | Revenue Growth (next year): | 538.25% |
Latest Nutriband Inc. News
NTRB Breaking Stock News: Dive into NTRB Ticker-Specific Updates for Smart Investing
MT Newswires
15 days ago
Nutriband Receives Patent for Abuse, Misuse Deterrent Transdermal Systems in Macao
GlobeNewswire
15 days ago
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
GlobeNewswire
21 days ago
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
GlobeNewswire
22 days ago
Nutriband Signs Partnership Agreement with Charlotte FC
GlobeNewswire
2 months ago
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
Simply Wall St.
2 months ago
When Will Nutriband Inc. (NASDAQ:NTRB) Breakeven?
MT Newswires
2 months ago
Nutriband Formalizes Development Partnership for Abuse Deterrent Fentanyl Patch With Kindeva
GlobeNewswire
2 months ago
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
Compare NTRB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NTRB Nutriband Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.